Dingal, Prince Jay P.

HRN: 21-39-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2023
MUPIROCIN 2%, 15G (TUBE)
05/28/2023
06/04/2023
TOPICAL
1g
TID
Cellulitis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: